Phase 2 Trial of Acalabrutinib-Lenalidomide-Rituximab (ALR) with Real-Time Monitoring of MRD in Patients with Treatment-Naïve Mantle Cell Lymphoma
Jia Ruan, John P. Leonard, Gui Zhen Chen, Zhengming Chen, John N. Allan, Sarah C. Rutherford, Brittany Hobbie, Katie Greig, Amelyn Rodriguez, Wayne Tam, David A. Bond, Bijal Shah, Kami J. Maddocks, Bhavneet Binder, Giorgio Inghirami, Olivier Elemento, Selina Chen‐Kiang, Peter Martin
Topics & Concepts
LenalidomideMantle cell lymphomaMedicineRituximabInternal medicineOncologyLymphomaMultiple myelomaLymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchT-cell and Retrovirus Studies